Press releases
- Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
- Prothena Reports First Quarter 2024 Financial Results and Business Highlights
- Prothena to Report First Quarter 2024 Financial Results on May 8
- Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
Key statistics
On Monday, Prothena Corporation PLC (0Y3M:LSE) closed at 20.34, 7.39% above its 52-week low of 18.94, set on Jun 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 20.34 |
Low | 20.34 |
Bid | -- |
Offer | -- |
Previous close | 19.99 |
Average volume | 105.17 |
---|---|
Shares outstanding | 53.77m |
Free float | 47.09m |
P/E (TTM) | -- |
Market cap | 1.09bn USD |
EPS (TTM) | -3.25 USD |
Data delayed at least 20 minutes, as of Jul 08 2024 14:30 BST.
More ▼